Business Description
M1 Kliniken AG
ISIN : DE000A0STSQ8
Total Employee Number:
300Compare
Compare
Traded in other countries / regions
M12.GermanyMKLNF.USA IPO Date
2021-02-04Description
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.56 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.18 | |||||
Interest Coverage | 23.87 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 8.85 | |||||
Beneish M-Score | -3.37 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.5 | |||||
3-Year EBITDA Growth Rate | 33.2 | |||||
3-Year EPS without NRI Growth Rate | 79.3 | |||||
3-Year FCF Growth Rate | 25.8 | |||||
3-Year Book Growth Rate | 7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | -28.91 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.82 | |||||
Quick Ratio | 1.82 | |||||
Cash Ratio | 1.48 | |||||
Days Inventory | 43.87 | |||||
Days Sales Outstanding | 11.34 | |||||
Days Payable | 15.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.4 | |||||
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 3.14 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.68 | |||||
Operating Margin % | 10.09 | |||||
Net Margin % | 6.08 | |||||
EBITDA Margin % | 11.11 | |||||
FCF Margin % | 10.39 | |||||
OCF Margin % | 10.42 | |||||
ROE % | 19.3 | |||||
ROA % | 11.44 | |||||
ROIC % | 19.03 | |||||
3-Year ROIIC % | 340.81 | |||||
ROC (Joel Greenblatt) % | 149.13 | |||||
ROCE % | 23.33 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.88 | |||||
Forward PE Ratio | 9.26 | |||||
PE Ratio without NRI | 15.17 | |||||
Shiller PE Ratio | 31.87 | |||||
Price-to-Owner-Earnings | 8.68 | |||||
PEG Ratio | 0.72 | |||||
PS Ratio | 1.01 | |||||
PB Ratio | 2.96 | |||||
Price-to-Tangible-Book | 11.97 | |||||
Price-to-Free-Cash-Flow | 9.77 | |||||
Price-to-Operating-Cash-Flow | 9.74 | |||||
EV-to-EBIT | 9.7 | |||||
EV-to-EBITDA | 8.53 | |||||
EV-to-Revenue | 0.95 | |||||
EV-to-FCF | 9.13 | |||||
Price-to-GF-Value | 1.19 | |||||
Price-to-Projected-FCF | 1.13 | |||||
Price-to-DCF (Earnings Based) | 0.53 | |||||
Price-to-DCF (FCF Based) | 0.15 | |||||
Price-to-Median-PS-Value | 0.61 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.72 | |||||
Price-to-Graham-Number | 2.84 | |||||
| Price-to-Net-Current-Asset-Value | 17.77 | |||||
Earnings Yield (Greenblatt) % | 10.31 | |||||
FCF Yield % | 10.66 | |||||
Forward Rate of Return (Yacktman) % | 25.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MKLNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
M1 Kliniken AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 423.357 | ||
| EPS (TTM) ($) | 1.382 | ||
| Beta | 0.0024 | ||
| 3-Year Sharpe Ratio | -59.39 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | 4.96 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 11.7284 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 11.7284 - 11.7284 | ||
| Shares Outstanding (Mil) | 18.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
M1 Kliniken AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
M1 Kliniken AG Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| EUR 1.200000 Cash Dividend | 2026-07-09 | In 5 days | ||
| EUR 0.500000 Cash Dividend | 2025-07-17 | 11.73 (+0.00%) | ||
| EUR 0.500000 Cash Dividend | 2024-07-18 | 11.73 (+0.00%) |
Show
Entries
M1 Kliniken AG Frequently Asked Questions
What is M1 Kliniken AG(MKLNF)'s stock price today?
The current price of MKLNF is $11.73. The 52 week high of MKLNF is $11.73 and 52 week low is $11.73.
When is next earnings date of M1 Kliniken AG(MKLNF)?
The next earnings date of M1 Kliniken AG(MKLNF) is .
Does M1 Kliniken AG(MKLNF) pay dividends? If so, how much?
M1 Kliniken AG(MKLNF) does not pay dividend.
Guru Commentaries on OTCPK:MKLNF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on M1 Kliniken AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers